SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-279614
Filing Date
2010-12-14
Accepted
2010-12-13 19:09:34
Documents
3
Period of Report
2010-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15519
2 LETTER IN REGARD TO AGREEMENT TERM EXTENSION, DATED DECEMBER 8, 2010 dex101.htm EX-10.1 5012
3 GRAPHIC g127347g80m31.jpg GRAPHIC 18330
  Complete submission text file 0001193125-10-279614.txt   47661
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 101249128
SIC: 2835 In Vitro & In Vivo Diagnostic Substances